Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis.

Tassone F, Baffoni C, Gianotti L, Pellegrino M, Magro G, Cesario F, Maccario M, Borretta G.

Minerva Endocrinol. 2015 Mar 24. [Epub ahead of print] No abstract available.

PMID:
25801016
2.

Challenging clinical cases in HCV infection.

Strazzulla A, Matera G, Mammone SV, Vaccaro V, Pisani V, Costa C, Manti F, Doldo P, Cosco L, Quintieri F, Cesario F, Liberto MC, Giancotti A, Torti C, Focà A.

BMC Infect Dis. 2014;14 Suppl 5:S7. doi: 10.1186/1471-2334-14-S5-S7. Epub 2014 Sep 5.

3.

Update on epidemiology of HCV in Italy: focus on the Calabria Region.

Marascio N, Liberto M, Barreca G, Zicca E, Quirino A, Lamberti A, Bianco G, Matera G, Surace L, Berardelli G, Surace L, De Maria V, Giancotti F, Leone R, Villella V, Nisticò S, Borelli A, Caruso V, Calderazzo M, Griffo G, Masciari R, Minchella P, Cosco L, Laganà C, Oliva A, Foti G, Fiorillo M, Bocchiaro G, Surace P, Ciccaglione A, Ciccozzi M, Cesario F, Torti C, Focà A.

BMC Infect Dis. 2014;14 Suppl 5:S2. doi: 10.1186/1471-2334-14-S5-S2. Epub 2014 Sep 5. Review.

4.

Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.

Gianotti L, Tassone F, Baffoni C, Pellegrino M, Cassibba S, Castellano E, Magro G, Cesario F, Visconti G, Borretta G.

Clin Endocrinol (Oxf). 2014 Sep;81(3):350-5. doi: 10.1111/cen.12472. Epub 2014 May 19.

PMID:
24750210
5.

Insulin sensitivity in normocalcaemic primary hyperparathyroidism.

Tassone F, Maccario M, Gianotti L, Baffoni C, Pellegrino M, Cassibba S, Cesario F, Magro G, Borretta G.

Endocrine. 2013 Dec;44(3):812-4. doi: 10.1007/s12020-013-0059-z. Epub 2013 Sep 25. No abstract available.

PMID:
24065311
6.

Vitamin D status in primary hyperparathyroidism: a Southern European perspective.

Tassone F, Gianotti L, Baffoni C, Visconti G, Pellegrino M, Cassibba S, Croce CG, Magro G, Cesario F, Attanasio R, Borretta G.

Clin Endocrinol (Oxf). 2013 Dec;79(6):784-90. doi: 10.1111/cen.12210. Epub 2013 Apr 17.

PMID:
23521111
7.

Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology).

Torti C, Zazzi M, Abenavoli L, Trapasso F, Cesario F, Corigliano D, Cosco L, Costa C, Curia RL, De Rosa M, Foti G, Giraldi C, Leone R, Liberto MC, Lucchino D, Marascio N, Masciari R, Matera G, Pisani V, Serrao N, Surace L, Zicca E, Castelli F, Ciccozzi M, Puoti M, Focà A; SINERGIE Study Group.

BMC Infect Dis. 2012;12 Suppl 2:S9. doi: 10.1186/1471-2334-12-S2-S9. Epub 2012 Nov 12. Review.

8.

Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism.

Tassone F, Gianotti L, Baffoni C, Cesario F, Magro G, Pellegrino M, Emmolo I, Maccario M, Borretta G.

J Endocrinol Invest. 2012 Oct;35(9):841-6. doi: 10.3275/8192. Epub 2011 Dec 21.

PMID:
22189414
9.

Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism.

Gianotti L, Piovesan A, Croce CG, Pellegrino M, Baffoni C, Cesario F, Visconti G, Borretta G, Tassone F.

Calcif Tissue Int. 2011 Mar;88(3):231-7. doi: 10.1007/s00223-010-9453-1. Epub 2011 Jan 5.

PMID:
21207016
10.

[Renal function in primary hyperparathyroidism].

Borretta G, Gianotti L, Cesario F, Borretta V, Tassone F.

G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S91-5. Italian.

PMID:
20922703
11.

A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.

Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G.

J Clin Endocrinol Metab. 2006 Aug;91(8):3011-6. Epub 2006 May 30.

PMID:
16735490
12.

Infections and thalassaemia.

Vento S, Cainelli F, Cesario F.

Lancet Infect Dis. 2006 Apr;6(4):226-33. Review.

PMID:
16554247
13.

Unexpected results using rapid intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.

Emmolo I, Corso HD, Borretta G, Visconti G, Piovesan A, Cesario F, Borghi F.

World J Surg. 2005 Jun;29(6):785-8.

PMID:
15883666
14.

A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia.

Pia A, Piovesan A, Tassone F, Razzore P, Visconti G, Magro G, Cesario F, Terzolo M, Borretta G.

J Endocrinol Invest. 2004 Dec;27(11):1060-4.

PMID:
15754739
15.

Proinsulin-secreting neuroendocrine tumor of the pancreas.

Piovesan A, Pia A, Visconti G, Terzolo M, Leone A, Magro G, Cesario F, Borretta G.

J Endocrinol Invest. 2003 Aug;26(8):758-61.

PMID:
14669832
16.

The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism.

Procopio M, Magro G, Cesario F, Piovesan A, Pia A, Molineri N, Borretta G.

Diabet Med. 2002 Nov;19(11):958-61.

PMID:
12421435
17.

The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.

Terzolo M, Reimondo G, Alì A, Borretta G, Cesario F, Pia A, Paccotti P, Angeli A.

Clin Endocrinol (Oxf). 2001 May;54(5):609-16.

PMID:
11380491
18.

Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.

Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G.

Clin Endocrinol (Oxf). 1999 Mar;50(3):321-8.

PMID:
10435057
19.

Subclinical Cushing's syndrome in adrenal incidentaloma.

Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.

Clin Endocrinol (Oxf). 1998 Jan;48(1):89-97.

PMID:
9509073
20.

Combined cabergoline and recombinant human growth hormone treatment of an adolescent with a macroprolactinoma causing GH deficiency.

Cesario F, Borretta G, Meineri I, Muratori M, Pizzocaro A, Beck-Peccoz P.

J Pediatr Endocrinol Metab. 1997 Mar-Apr;10(2):231-6.

PMID:
9364359
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk